AcuraBio
Manufacturing · 51-200 Employees
View Company Info for Free
Overview
Phone Number
+61 732739176Website
www.acurabio.comRevenue
<$5 MillionIndustry
About AcuraBio
Is AcuraBio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when AcuraBio launches new products
Check out if AcuraBio is spiking on competitors!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at AcuraBio
Check if AcuraBio has recently received funding, and reach out quickly before it becomes old news!
AcuraBio, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on AcuraBio recently announced quarterly report
Click to see if AcuraBio had a recent Job posting/layoffs
Funding: Get notified immidiatlly once AcuraBio has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
AcuraBio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
AcuraBio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about AcuraBio.
AcuraBio Tech Stack
A closer look at the technologies used by AcuraBio
AcuraBio News & Media
AcuraBio expands cGMP plasmid DNA CDMO services with Cytiva's latest single-use purification technology to alleviate supply constraints for mRNA and cell & gene therapies
AcuraBio selects Cytiva's latest two-step purification protocol to offer a productive plasmid DNA service to its customers globally to alleviate supply constraints for mRNA and cell & gene therapies The latest purification technology will offer efficient processing time for plasmid DNA production BRISBANE, Australia, Feb. 10, 2023 /PRNewswire/ -- AcuraBio, a leading Australian biopharmaceutical contract development and manufacturing organization (CDMO), will provide a cGMP plasmid DNA CDMO serviAcuraBio Appoints Talented Senior Executives to Drive Global Growth Program
BRISBANE, AUS, Oct 18, 2022 - (ACN Newswire) - AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, recently acquired by biotech investor Dr. Glenn Haifer and Ampersand Capital Partners, announced today new senior executive hires to support global growth plans. International biopharma executive Guillaume Herry has been appointed as CEO, while HR executive Joanne Reichardt has been appointed Head of People & Culture. AcuraBio CEO Guillaume Herry AcuraBio brings two decades
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AcuraBio
AcuraBio is an Australia-based contract development and manufacturing organization (CDMO) that provides development and biomanufacturing to the pharmaceutical, biotechnology, and veterinary industries.... Read More